Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-04-19

Clinical Trial Update: Safety Study of UC-781 Vaginal Microbicide [Phase 1]

View source ↗

Summary

A Phase 1 safety study of UC-781 vaginal microbicide for HIV prevention has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • UC-781 vaginal microbicide (UC-781)

Snippet

Sponsor: Centers for Disease Control and Prevention | Conditions: HIV Infections | Phase 1 | Status: COMPLETED